Alexandria Capital’s Core Laboratories CLB Stock Holding History

Alexandria Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-13	Closed	-$1K	–	607
2016 Q1	$1K	Sell	13 -3	-19%	-$312	﹤0.01%	573
2015 Q4	$2K	Hold	16	–	–	﹤0.01%	594
2015 Q3	$2K	Sell	16 -1	-6%	-$109	﹤0.01%	539
2015 Q2	$2K	Sell	17 -2	-11%	-$243	﹤0.01%	556
2015 Q1	$2K	Hold	19	–	–	﹤0.01%	562
2014 Q4	$2K	Buy	+19	New	+$2.5K	﹤0.01%	527

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Alexandria Capital's CLB Position: Q2 2016 in Review

Alexandria Capital sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 13 shares — an estimated $1K sold.

Alexandria Capital first reported a position in CLB in Q4 2014 and held it in 6 quarters. The position peaked at $2K in Q4 2015. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

Alexandria Capital reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
Alexandria Capital sold 13 Core Laboratories shares in Q2 2016, an estimated $1K.
Alexandria Capital first reported a position in Core Laboratories in Q4 2014 and held it in 6 quarters.
Alexandria Capital's Core Laboratories position peaked at $2K in Q4 2015.
383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Alexandria Capital's 13F filing for Q2 2016, filed 4 Aug 2016.